Acellular pertussis vaccine given by accelerated schedule: response of preterm infants

M H Slack1, D Schapira, R J Thwaites

  • 1Department of Paediatrics, St Mary's Hospital, Portsmouth, UK. marts@doctors.org.uk

Insights

Preterm infants showed reduced antibody responses to pertussis toxin after DTaP vaccination on an accelerated schedule. Antibody levels for tetanus, FHA, and PRN increased with infant age and gestational age at birth.

Area of Science:

  • Immunology
  • Neonatal Medicine
  • Vaccinology

Background:

  • Preterm infants often exhibit altered immune responses compared to term infants.
  • Vaccination schedules are critical for ensuring adequate protection in vulnerable populations.
  • The impact of antenatal and postnatal steroid exposure on infant immunity requires further investigation.

Purpose of the Study:

  • To evaluate the immune response of preterm infants to an accelerated diphtheria/tetanus/three component acellular pertussis (DTaP) vaccine schedule.
  • To assess the influence of antenatal and postnatal steroid exposure on vaccine immunogenicity in preterm infants.
  • To compare the immune responses of preterm infants with those of term infants.

Main Methods:

  • A prospective observational study involving 130 preterm infants (mean gestational age 29.1 weeks) and 54 term infants.
  • Administration of the DTaP-Haemophilus influenzae type b vaccine at 2, 3, and 4 months of age.
  • Measurement of IgG geometric mean concentrations (GMC) to vaccine antigens via blood samples.

Main Results:

  • Preterm infants had significantly lower IgG GMC to pertussis toxin (PT) compared to term infants after the third DTaP immunisation.
  • Antibody responses to diphtheria, tetanus, filamentous haemagglutinin (FHA), and pertactin (PRN) were comparable between preterm and term infants.
  • Higher gestational age at birth and older age at the third immunisation correlated with increased antibody responses to several vaccine antigens.

Conclusions:

  • Preterm infants receiving an accelerated DTaP vaccination schedule exhibit a reduced IgG GMC to pertussis toxin.
  • Immune responses to tetanus, FHA, and PRN are positively influenced by gestational age at birth and age at immunisation.
  • Antenatal steroid exposure was associated with decreased anti-tetanus IgG levels, while postnatal steroids had no significant effect.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...